Holmøy Trygve - Akershus University Hospital and Institute of Clinical Medicine, University of Oslo

基本信息

浏览量：60

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 218 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population-Based Cohort Study

Anders Myhre Vaage,Trygve Holmøy,Jesper Dahl,Hein Stigum,Haakon E Meyer,Ola Nakken

European journal of neurologyno. 3 (2025): e70095-e70095

引用0浏览0WOS引用

Immunogenicity, Efficacy and Safety of Mrna-Covid-19 Vaccines in People with Multiple Sclerosis Who Underwent Treatment with Autologous Hematopoietic Stem Cell Therapy

Stine Schikora-Rustad, Tilde Rasmussen,Adity Chopra,Trung Tran,Anne Kristine Lehmann,Stig Wergeland,Einar Hogestol,Trygve Holmoy,Lars Bo,Elisabeth G. Celius,John Vaage,Oivind Torkildsen,Gro Nygaard,Aslaug Rudjord Lorentzen,Fridtjof Lund-Johansen,Marton Konig

MULTIPLE SCLEROSIS JOURNALno. 3 (2024): 360-360

引用0浏览0引用

Low Disease Activity over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study (P10-6.007)

Timothy Vollmer,Robert Bermel,Bruno Brochet,Thomas Berger,William Carroll,Mark Freedman,Trygve Holmoy,Rana Karabudak,Joep Killestein,Carlos Nos,Francesco Patti,Ludo Vanopdenbosch,Thomas Kuenzel,Karen Kadner,Inessa Kulyk,Hans-Peter Hartung

Neurology（2024）

引用0浏览0引用

Repeat Expansions in AR, ATXN1, ATXN2 and HTT in Norwegian Patients Diagnosed with Amyotrophic Lateral Sclerosis

Camilla Novy,Oyvind L. Busk,Ole-Bjorn Tysnes, Sigve S. Landa, Tori N. Aanjesen,Karl B. Alstadhaug,Tale L. Bjerknes, Ingrid K. Bjorna,Geir Brathen, Elin Dahl,Natasha Demic, Maria Fahlstrom, Heidi O. Flemmen, Erika Hallerstig, Ineke HogenEsch,Margitta T. Kampman,Grethe Kleveland, Helene B. Kvernmo,Unn Ljostad,Angelina Maniaol, Aase Hagen Morsund,Ola Nakken, Cathrine G. Olsen,Katrin Schluter, May-Sissel Utvik, Ryaz Yaseen,Oystein L. Holla,Trygve Holmoy,Helle Hoyer

Brain Communications（2024）

引用1浏览0WOS引用

BCG Vaccination and Multiple Sclerosis Risk: A Norwegian Cohort Study

Ola Nakken,Jan Harald Aarseth,Stig Wergeland,Hein Stigum,Haakon E. Meyer,Trygve Holmoy

MULTIPLE SCLEROSIS JOURNALno. 6 (2024): 646-653

引用0浏览0WOS引用

Effect of Autologous Stem Cell Transplantation on Chronic Active Lesions in Multiple Sclerosis

Einar Hogestol, Rigmor Lundby,Lars Skattebol,Piotr Sowa,Trygve Holmoy,Hanne Flinstad Harbo,Elisabeth G. Celius,Marton Konig,Tobias Gedde-Dahl,Wibeke Nordhoy,Gro Nygaard

MULTIPLE SCLEROSIS JOURNALno. 3 (2024): 932-932

引用0浏览0引用

Prevalence and Geographic Distribution of the C9orf72 Expansion among Norwegian ALS Patients

Cathrine Goberg Olsen,Karl Bjornar Alstadhaug, Ingrid Kristine Bjorna, Bahri Bunjaku,Natasha Demic, Gun Anna Maria Fahlstrom,Heidi Oyen Flemmen, Roelfien Ida HogenEsch,Margitta Kampman,Grethe Kleveland, Silje Korsnes, Helene Kvernmo,Unn Ljostad,Angelina Maniaol,Ase Hagen Morsund,Camilla Novy,Katrin Schluter,Stephan Schuler,Ole-Bjorn Tysnes,Trygve Holmoy,Helle Hoyer

EUROPEAN JOURNAL OF HUMAN GENETICS (2024): 497-497

引用0浏览0引用

Association of UNC13A with Increased Amyotrophic Lateral Sclerosis Risk, Bulbar Onset, and Lower Motor Neuron Involvement in a Norwegian ALS Cohort

Camilla Novy,Ole-Bjorn Tysnes,oyvind L. Busk, Keson Jaioun,Trygve Holmoy,oystein L. Holla,Helle Hoyer

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2024)

引用0浏览0WOS引用

Norsk Helsevesen Bør Tilby Stamcellebehandling Mot Multippel Sklerose

Gro Owren Nygaard,Trygve Holmoy

TIDSSKRIFT FOR DEN NORSKE LAEGEFORENINGno. 2 (2024)

引用0浏览0引用

Faible Activité De La Maladie Après Un Traitement De 4 Ans Par Ocrelizumab (OCR) Chez Des Patients Naïfs De Traitement Atteints De Sclérose En Plaques Récurrente-Rémittente (SEP-RR) À Un Stade Précoce ; Données De L’étude De Phase IIIb Ensemble

Bruno Brochet,Francesco Patti,Robert Bermel,Thomas Berger, William-M. Carroll,Trygve Holmøy,Rana Karabudak

Revue Neurologique（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn